CHMX · As filed with the SEC
NEXT-ChemX income statement, by quarter
The statement as NEXT-ChemX presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Condensed Statements of Operations (Unaudited) · USD, except per-share amounts
| USD, except per-share amounts | Q2 2025 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 | Q3 2024 3 months ended Sep 30, 2024 |
|---|---|---|---|---|
| Operating expenses | ||||
| Selling, General and Administrative Expense | — | — | — | 319,441 |
| Total Costs and Expenses | 177,744 | 174,000 | — | — |
| Professional Fees | 158,322 | 158,222 | — | — |
| Depreciation Expense | 38,692 | 38,780 | — | — |
| Other operating Expenses | 16,826 | 43,760 | — | — |
| Total operating expenses | 391,584 | 414,762 | 571,031† | 319,441 |
| Income (loss) from operations | (391,584) | (414,762) | (571,031)† | (319,441) |
| Other income (expense) | ||||
| Non-Operating Income (Expense) | 6,264 | 12,801 | 34,445† | 14,401 |
| Interest expense | (70,319) | (63,965) | (58,349)† | (49,455) |
| Net other Income (expense) | (64,055) | (51,164) | (23,904)† | (35,054) |
| Net income (loss) | (455,639) | (465,926) | (594,935)† | (354,495) |
| Earnings Per Share (Basic) | (0.02) | (0.02) | — | (0.01) |
| Earnings Per Share (Diluted) | (0.02) | (0.02) | — | (0.01) |
| Weighted Average Shares Outstanding | 28,546,834 | 28,546,834 | — | 28,546,834 |
| Weighted Average Shares Outstanding, Diluted | 28,546,834 | 28,546,834 | — | 28,546,834 |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.